Inspire Medical Systems (INSP)
(Delayed Data from NYSE)
$212.85 USD
+0.75 (0.35%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $212.97 +0.12 (0.06%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth C Momentum C VGM
Price, Consensus and EPS Surprise
INSP 212.85 +0.75(0.35%)
Will INSP be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for INSP based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for INSP
Here's Why Inspire Medical Systems (INSP) is a Strong Momentum Stock
Here's Why Inspire Medical Systems (INSP) is a Strong Momentum Stock
INSP: What are Zacks experts saying now?
Zacks Private Portfolio Services
How to Find Strong Buy Medical Stocks Using the Zacks Rank
How to Find Strong Buy Medical Stocks Using the Zacks Rank
Zacks Industry Outlook Highlights Medical Systems, Clover Health Investments and CareCloud
Other News for INSP
InspireSemi Announces Final Closing of Private Placement
InspireSemi Completes Funding Round, Bolsters Capital
Inspire Medical Systems Inc (INSP) Trading 3.23% Higher on Sep 16
Fidelity Select Health Care Portfolio Q2 2024 Review
Inspire Medical price target raised by $30 at Leerink, here's why